Dose-Finding Study of E7070 in Combination With Irinotecan

NCT00060567 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

88

Enrollment

INDUSTRY

Sponsor class

Conditions

Cancer

Interventions

DRUG: E7070 + irinotecan combination
DRUG: Irinotecan + E7070 combination
DRUG: Irinotecan + E7070 combination

Sponsor

Eisai Inc.